Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?


Journal

F1000Research
ISSN: 2046-1402
Titre abrégé: F1000Res
Pays: England
ID NLM: 101594320

Informations de publication

Date de publication:
2019
Historique:
accepted: 15 03 2019
entrez: 16 4 2019
pubmed: 16 4 2019
medline: 12 5 2020
Statut: epublish

Résumé

Acute pulmonary embolism (PE) is a disease frequently encountered in clinical practice. While the management of haemodynamically stable, low risk patients with acute PE is well established, managing intermediate disease often presents a therapeutic dilemma. In this review, we discuss the various therapeutic options available in this patient group. This includes thrombolysis, surgical embolectomy and catheter directed techniques. We have also explored the role of specialist PE response teams in the management of such patients. ​.

Identifiants

pubmed: 30984375
doi: 10.12688/f1000research.17861.1
pmc: PMC6436190
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

Competing interests: KS is a member of the UK’s National Institute for Health and Care Excellence and British Thoracic Society’s Venous Thromboembolism guideline groups. She has received education support from Actelion, Bayer and GSK and has been on an advisory board for Actelion. AB and JPZ have no competing interests. No competing interests were disclosed.No competing interests were disclosed.

Références

Am J Emerg Med. 2016 Nov;34(11):2259.e5-2259.e6
pubmed: 27266329
Chest. 2016 Feb;149(2):315-352
pubmed: 26867832
Eur Heart J. 2014 Nov 14;35(43):3033-69, 3069a-3069k
pubmed: 25173341
Blood. 2015 Apr 2;125(14):2191-9
pubmed: 25631770
J Thromb Haemost. 2014 Jul;12(7):1086-95
pubmed: 24829097
Circulation. 2004 Aug 10;110(6):744-9
pubmed: 15262836
EuroIntervention. 2018 Nov 20;14(10):1136-1143
pubmed: 30082262
Vasc Endovascular Surg. 2016 Aug;50(6):405-10
pubmed: 27630267
J Vasc Interv Radiol. 2009 Nov;20(11):1431-40
pubmed: 19875060
Cochrane Database Syst Rev. 2015 Sep 30;(9):CD004437
pubmed: 26419832
Cochrane Database Syst Rev. 2017 Feb 09;2:CD001100
pubmed: 28182249
Thromb Haemost. 2007 Oct;98(4):756-64
pubmed: 17938798
J Thorac Cardiovasc Surg. 2008 Aug;136(2):448-51
pubmed: 18692656
Chest. 2015 Sep;148(3):667-673
pubmed: 25856269
J Am Coll Cardiol. 1997 Nov 1;30(5):1165-71
pubmed: 9350909
Arch Intern Med. 2007 May 14;167(9):935-43
pubmed: 17502535
Circulation. 2011 Apr 26;123(16):1788-830
pubmed: 21422387
J Thorac Cardiovasc Surg. 2005 May;129(5):1018-23
pubmed: 15867775
Chest. 2010 Feb;137(2):254-62
pubmed: 19741062
Am J Cardiol. 2013 Jan 15;111(2):273-7
pubmed: 23102885
JACC Cardiovasc Interv. 2019 May 13;12(9):859-869
pubmed: 31072507
JACC Cardiovasc Interv. 2015 Aug 24;8(10):1382-1392
pubmed: 26315743
Chest. 1994 Sep;106(3):725-6
pubmed: 8082348
N Engl J Med. 2014 Apr 10;370(15):1402-11
pubmed: 24716681
Lancet. 1999 Apr 24;353(9162):1386-9
pubmed: 10227218
Thromb Haemost. 1997 Sep;78(3):1063-8
pubmed: 9308755
JACC Cardiovasc Interv. 2018 Jul 23;11(14):1401-1410
pubmed: 30025734
Resuscitation. 2013 Oct;84(10):1365-70
pubmed: 23583612
Eur Heart J. 2015 Mar 7;36(10):605-14
pubmed: 24917641
Chest. 2016 Aug;150(2):384-93
pubmed: 27006156
J Thorac Cardiovasc Surg. 2018 Mar;155(3):1084-1090.e12
pubmed: 28942971
Perfusion. 2016 Nov;31(8):703-705
pubmed: 27113394
J Vasc Interv Radiol. 2003 Dec;14(12):1511-5
pubmed: 14654484
Eur J Cardiothorac Surg. 2017 Feb 1;51(2):354-361
pubmed: 28186234
JAMA. 2014 Jun 18;311(23):2414-21
pubmed: 24938564
J Vasc Surg Venous Lymphat Disord. 2019 Jul;7(4):493-500
pubmed: 30930079
Ann Thorac Surg. 2016 Nov;102(5):1498-1502
pubmed: 27373187
Circulation. 2014 Jan 28;129(4):479-86
pubmed: 24226805
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD004437
pubmed: 19588357
Hosp Pract (1995). 2014 Feb;42(1):31-7
pubmed: 24566594
Thorax. 2018 May;73(5):464-471
pubmed: 29133351
J Am Coll Cardiol. 2000 Aug;36(2):375-80
pubmed: 10933345
Ther Adv Drug Saf. 2015 Apr;6(2):57-66
pubmed: 25922654
Eur J Cardiothorac Surg. 2013 Jan;43(1):90-4; discussion 94
pubmed: 22466693
Heart Lung. 2015 Jul-Aug;44(4):335-9
pubmed: 26077690
Ther Adv Cardiovasc Dis. 2016 Apr;10(2):103-10
pubmed: 26864121
Pulm Circ. 2018 Oct-Dec;8(4):2045894018800265
pubmed: 30142025
J Thorac Cardiovasc Surg. 2018 Mar;155(3):1095-1106.e2
pubmed: 29452460

Auteurs

Amyn Bhamani (A)

Department of Respiratory Medicine, Basildon and Thurrock University Hospital, Basildon, Essex, SS16 5NL.

Joanna Pepke-Zaba (J)

Pulmonary Vascular Diseases Unit, Royal Papworth Hospital, Cambridge, CB23 3RE.

Karen Sheares (K)

Pulmonary Vascular Diseases Unit, Royal Papworth Hospital, Cambridge, CB23 3RE.
Department of Respiratory Medicine, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH